- Home
- MLTX vs CYRX Comparison
MLTX vs CYRX Comparison
Compare MLTX & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLTX
- CYRX
- Stock Information
- Founded
- MLTX 2021
- CYRX 1999
- Country
- MLTX Switzerland
- CYRX United States
- Employees
- MLTX N/A
- CYRX N/A
- Industry
- MLTX Biotechnology: Pharmaceutical Preparations
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- MLTX Health Care
- CYRX Health Care
- Exchange
- MLTX Nasdaq
- CYRX Nasdaq
- Market Cap
- MLTX 535.3M
- CYRX 438.7M
- IPO Year
- MLTX N/A
- CYRX N/A
- Fundamental
- Price
- MLTX $9.40
- CYRX $9.80
- Analyst Decision
- MLTX Buy
- CYRX Strong Buy
- Analyst Count
- MLTX 9
- CYRX 10
- Target Price
- MLTX $37.63
- CYRX $12.20
- AVG Volume (30 Days)
- MLTX 9.7M
- CYRX 573.5K
- Earning Date
- MLTX 11-06-2025
- CYRX 11-06-2025
- Dividend Yield
- MLTX N/A
- CYRX N/A
- EPS Growth
- MLTX N/A
- CYRX N/A
- EPS
- MLTX N/A
- CYRX 1.35
- Revenue
- MLTX N/A
- CYRX $237,879,000.00
- Revenue This Year
- MLTX N/A
- CYRX N/A
- Revenue Next Year
- MLTX N/A
- CYRX $9.09
- P/E Ratio
- MLTX N/A
- CYRX $7.26
- Revenue Growth
- MLTX N/A
- CYRX 24.93
- 52 Week Low
- MLTX $5.95
- CYRX $4.58
- 52 Week High
- MLTX $62.75
- CYRX $10.46
- Technical
- Relative Strength Index (RSI)
- MLTX 23.29
- CYRX 56.74
- Support Level
- MLTX $6.56
- CYRX $9.28
- Resistance Level
- MLTX $7.48
- CYRX $9.81
- Average True Range (ATR)
- MLTX 2.22
- CYRX 0.47
- MACD
- MLTX -4.37
- CYRX -0.02
- Stochastic Oscillator
- MLTX 6.07
- CYRX 52.47
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.